Publications by authors named "Siddharth J Modi"

Claim this Profile
A
A bibliometric and critical trend analysis of the anti-cancer potential of Withania somnifera during 2000-2024.
Lal Hingorani, Manolina Karmakar, Souvik Mukherjee, Siddharth J Modi, Vallabh Mulay

Naunyn Schmiedebergs Arch Pharmacol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Saffron (Crocus sativus L.) extract attenuates chronic scopolamine-induced cognitive impairment, amyloid beta, and neurofibrillary tangles accumulation in rats.
Komal S Patel, Abhay Dharamsi, Madhu Priya, Sanskar Jain, Vishal Mandal, Siddharth J Modi

J Ethnopharmacol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical pharmacokinetic evaluation of Withania somnifera (L.) Dunal root extract in healthy human volunteers: A non-randomized, single dose study utilizing UHPLC-MS/MS analysis.
Vidyadhar G Vaidya, Ninad N Naik, Gayatri Ganu, Vijay Parmar, Shubham Jagtap, Siddharth J Modi

J Ethnopharmacol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical safety and tolerability evaluation of Withania somnifera (L.) Dunal (Ashwagandha) root extract in healthy human volunteers.
Vidyadhar G Vaidya, Amol Gothwad, Gayatri Ganu, Aboli Girme, Siddharth J Modi

J Ayurveda Integr Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Network pharmacology-based strategic prediction and target identification of apocarotenoids and carotenoids from standardized Kashmir saffron (Crocus sativus L.) extract against polycystic ovary syndrome.
Anshuly Tiwari, Siddharth J Modi, Aboli Girme, Lal Hingorani

Medicine (Baltimore)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibroblast growth factor receptor (FGFR) inhibitors as anticancer agents: 3D-QSAR, molecular docking and dynamics simulation studies of 1, 6-naphthyridines and pyridopyrimidines.
Dharti H Modh, Siddharth J Modi, Hemant Deokar, Savita Yadav, Vithal M Kulkarni

J Biomol Struct Dyn· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploration of structural requirements for the inhibition of VEGFR-2 tyrosine kinase: Binding site analysis of type II, 'DFG-out' inhibitors.
Siddharth J Modi, Vithal M Kulkarni

J Biomol Struct Dyn· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic Study of Withanosides and Withanolides from Using Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry (UHPLC-MS/MS).
Siddharth J Modi, Anshuly Tiwari, Chetana Ghule, Sandeep Pawar, Ganesh Saste

Molecules· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of piperine against cancer stem cells (CSCs) of hepatocellular carcinoma: Insights into epithelial-mesenchymal transition (EMT).
Anshuly Tiwari, Siddharth J Modi, Satish Y Gabhe, Vithal M Kulkarni

Bioorg Chem· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversal of TGF-β-induced epithelial-mesenchymal transition in hepatocellular carcinoma by sorafenib, a VEGFR-2 and Raf kinase inhibitor.
Siddharth J Modi, Anshuly Tiwari, Vithal M Kulkarni

Curr Res Pharmacol Drug Discov· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of VEGFR-2 inhibitors exerting significant anticancer activity against CD44+ and CD133+ cancer stem cells (CSCs): Reversal of TGF-β induced epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma.
Siddharth J Modi, Vithal M Kulkarni

Eur J Med Chem· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis